Fourth-Generation Biologics Set to Drive Over $120 Billion Market BOSTON, MA--(Marketwired - Jul 9, 2013) - Fourth-generation biologics, with improved delivery and pharmacokinetics, will continue to drive an overall biologics industry that is already worth over...